Gold River Productions, Inc. (GRPS) Fair Value 2026

GRPS · Drug Manufacturers - Specialty & Generic ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.1 /10

32 fundamental signals · 2 models active

Value Trap Risk

LOW (33/100)

Quick Summary — As of 2026-08-27, Gold River Productions, Inc. (GRPS) trades at $0.00, versus a $0.00 median fair value across its 2 active models — 340.7% above the current price. QOC: 4.1/10. Value Trap Risk: 33/100 (LOW). 2/13 models active.

Key Facts

Ticker
GRPS
Price
$0.00
Quality Score
4.1/10
Value Trap Risk
33/100
Models Active
2/13
Last Updated
Strength: PWERM suggests +448.5% upside with 27% confidence
Risk: Below-average Quality Score of 4.1/10 signals weak fundamentals

Is Gold River Productions, Inc. (GRPS) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Gold River Productions, Inc. (GRPS) appears undervalued as of : the median of 2 independent fair value estimates is $0.00, 340.7% above the current price of $0.00. Estimates range from $0.00 to $0.00. GRPS scores 4.1/10 on fundamental quality and 33/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. GRPS’s +340.7% gap is wider than that market norm, and the Drug Manufacturers - Specialty & Generic sector median is -1.4%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Gold River Productions, Inc. Stock in 2026? →

What Fair Value Does Each Model Give GRPS?

2 Intrinsic Value Models vs. Current Price ($0.00)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · Medium Conviction
 $0.00 +232.8%
Option-Based · Medium Conviction
 $0.00 +448.5%

All Models Active

All 2 models are displayed above.

What Is Gold River Productions, Inc. (GRPS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Gold River Productions, Inc.'s intrinsic value is estimated at a median fair value of $0.00. At a current market price of $0.00, 2 of 2 active valuation models identify upside potential, projecting a median implied return of +340.7%. Notably, PWERM sees the most upside at +448.5% (fair value: $0.00), while Dynamic NAV is the most conservative at +232.8% ($0.00). The spread between these extremes — +215.7% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About GRPS?

2 of 13 models are currently active for GRPS. All 2 active models suggest the stock trades below fair value. Taken together, their median fair value for GRPS is $0.00 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does GRPS Rank in Drug Manufacturers - Specialty & Generic?

Among 110 Drug Manufacturers - Specialty & Generic stocks, GRPS ranks #96 by Quality of Company score. CirclFi's QOC score of 4.1/10 evaluates 32 fundamental signals. A score of 4.1 reflects mixed fundamentals.

See all Most Undervalued Drug Manufacturers - Specialty & Generic Stocks →

The Drug Manufacturers - Specialty & Generic sector introduces analytical considerations specific to healthcare company businesses. For Gold River Productions, Inc., metrics like FDA approval probability provide important context that general-purpose valuation models may underweight.

Is GRPS a Value Trap?

CirclFi's Value Trap algorithm assigns GRPS a score of 33/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Gold River Productions, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Gold River Productions, Inc. scores 4.1 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +215.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every GRPS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across GRPS's 2 active models, average confidence is 35%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Gold River Productions, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Drug Manufacturers - Specialty & Generic Stocks Should You Also Analyze?

11 related Drug Manufacturers - Specialty & Generic stocks with 13-model coverage

BUDZWEED, Inc.QOC 4.2PTPIPetros Pharmaceuticals, Inc.QOC 4.1CBIHCannabis Bioscience International Holdings, Inc.QOC 4.3RDHLRedHill Biopharma Ltd.QOC 4.1KOANResonate Blends, Inc.QOC 4.4KAYSKaya Holdings, Inc.QOC 3.9ETSTEarth Science Tech, Inc.QOC 8.5SNOASonoma Pharmaceuticals, Inc.QOC 6.3TLPHTalphera, Inc.QOC 5.7UTHRUnited Therapeutics CorporationQOC 9.6AMPHAmphastar Pharmaceuticals, Inc.QOC 9.4

Read investment analysis: BUDZ · PTPI · CBIH · RDHL · KOAN · KAYS · ETST · SNOA · TLPH · UTHR · AMPH

Which Other Stocks Have a Similar Quality Score to GRPS?

7 companies across all industries closest to GRPS’s Quality of Company score of 4.1/10.

ARMPArmata Pharmaceuticals, Inc.QOC 4.1DBMMDigital Brand Media & Marketing Group, Inc.QOC 4.1BIOFBlue Biofuels, Inc.QOC 4.1GTBPGT Biopharma, Inc.QOC 4.1IMOImperial Oil LimitedQOC 4.1TVRDTvardi Therapeutics, Inc.QOC 4.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: ARMP · DBMM · BIOF · GTBP · IMO · TVRD · NVDA

Where Does GRPS Sit in CirclFi's Drug Manufacturers - Specialty & Generic Rankings?

GRPS is ranked against every other Drug Manufacturers - Specialty & Generic stock CirclFi covers in each of these screens.

See all Drug Manufacturers - Specialty & Generic stocks ranked →

What Else Do Investors Ask About Gold River Productions, Inc.’s Valuation?

What is Gold River Productions, Inc.'s intrinsic value in 2026?

CirclFi puts Gold River Productions, Inc. (GRPS)'s intrinsic value at $0.00 — the median of 2 independent model estimates as of 2026-08-27, ranging from $0.00 to $0.00. The Quality of Company score is 4.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is GRPS overvalued or undervalued right now?

At $0.00, 2 of 2 active models suggest GRPS may be undervalued, while 0 indicate potential overvaluation. The median of all 2 fair value estimates is $0.00, 340.7% above the current price of $0.00 — a consensus view that GRPS is undervalued. The assessment depends on which methodology best fits Gold River Productions, Inc.'s business model in Drug Manufacturers - Specialty & Generic.

What does a Quality of Company score of 4.1 mean for GRPS?

Gold River Productions, Inc.'s QOC of 4.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on GRPS?

CirclFi analyzes GRPS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is GRPS a value trap in 2026?

Gold River Productions, Inc.'s Value Trap score is 33/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Gold River Productions, Inc. (GRPS) has a median fair value of $0.00 — 340.7% above the current price of $0.00 — as of 2026-08-27.” Source: circlfi.com/stock/GRPS/ · Methodology
Primary sources for this GRPS valuation
  • Financial statements: Gold River Productions, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001990446) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for GRPS as of ; valuations recomputed .